Combination therapies in multiple sclerosis

@article{Gold2008CombinationTI,
  title={Combination therapies in multiple sclerosis},
  author={Ralf Gold},
  journal={Journal of Neurology},
  year={2008},
  volume={255},
  pages={51-60}
}
  • Ralf Gold
  • Published in Journal of Neurology 2008
  • Medicine
  • The last years have seen enormous progress in our understanding of pathophysiology of multiple sclerosis. In addition, the armamentarium of available immunomodulatory or immunosuppressive therapies has greatly increased, especially for the relapsing remitting form of the disease. Since their therapeutic efficacy is often limited in individual patients, it is conceivable that combination therapies may bring improved clinical efficacy while managing increasing side effects and toxicity. The… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 21 CITATIONS

    Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study

    Chemotherapeutics in the treatment of multiple sclerosis

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Immunomodulatory drug treatment in multiple sclerosis.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 43 REFERENCES

    A Double Blind , Placebo Controlled Trial of Atorvastatin in Combination with Subcutaneous Interferon Beta 1 a in Persons with Multiple Sclerosis

    • G Birnbaum, I Altafullah, R Reder
    • Neurology
    • 2007

    A Double Blind, Placebo Controlled Trial of Atorvastatin in Combination with Subcutaneous Interferon Beta 1a in Persons with Multiple Sclerosis. Neurology 68(Suppl 1):A206–A207

    • G Birnbaum, I Altafullah, R Reder
    • 2007
    VIEW 1 EXCERPT

    Glatiramer acetate combined with minocycline reduces the number of T1 Gd-enhancing and new T2 lesions compared to glatiramer actetate alone

    • L Metz, D Li, +5 authors V Yong
    • Neurology
    • 2007
    VIEW 1 EXCERPT

    Glatiramer acetate: mechanisms of action in multiple sclerosis.

    VIEW 1 EXCERPT

    Intramuscular Interferon Beta - 1 a , Azathioprine , and Corticosteroid Combination Therapy in Patients with RelapsingRemitting Multiple Sclerosis : 5 - Year Clinical Efficacy Results

    • E Havrdova, R Zivadinov, +8 authors D Horakova
    • Neurology
    • 2007

    Atorvastatin and glatiramer acetate: new hope in MS?

    VIEW 1 EXCERPT